CDTX vs IRM · rev $1.3M vs P/E 136, rev $6.15B
Cidara Therapeutics Inc (CDTX) versus Iron Mountain Incorporated (IRM) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Iron Mountain Incorporated (IRM) is a reit - specialty company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported IRM revenue for 2024-12-31 was $6.15B. Net income was $183.7M. Revenue was up 12.2% from 2023-12-31 to 2024-12-31. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
CDTX currently screens at market cap $6.96B. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
Not investment advice. Open the CDTX and IRM stock pages for the full models.
Not investment advice.